ADCE-T02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ADCE-T02, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours [Phase 1]